BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease

Vaccine

Volumn 25, Issue 28, 2007, Pages 5126-5132

  Tsenova, Liana ^a   Harbacheuski, Ryhor ^a   Sung, Nackmoon ^a   Ellison, Evette ^a   Fallows, Dorothy ^a   Kaplan, Gilla ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

BCG vaccination; M. tuberculosis strains; Rabbits; Tuberculous meningitis; W Beijing strains

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; TUBERCULOUS MENINGITIS; VACCINATION;

ANIMALS; BCG VACCINE; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; MENINGES; MYCOBACTERIUM TUBERCULOSIS; RABBITS; TREATMENT OUTCOME; TUBERCULOSIS; VIRULENCE;

EID: 34250163887     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.024     Document Type: Article

References (34)

1. Brewer T.F., and Colditz G.A. Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis 20 1 (1995) 126-135
2. Ginsberg A.M. The tuberculosis epidemic. Scientific challenges and opportunities. Public Health Rep 113 2 (1998) 128-136
3. Rodrigues L.C., Diwan V.K., and Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 22 6 (1993) 1154-1158
4. WHO. Global Tuberculosis Control (2000), World Health Organization, Geneva
5. Orme I.M. The search for new vaccines against tuberculosis. J Leukoc Biol 70 1 (2001) 1-10
6. Fine P.E. BCG: the challenge continues. Scand J Infect Dis 33 4 (2001) 243-245
7. Lagranderie M.R., Balazuc A.M., Deriaud E., Leclerc C.D., and Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 64 1 (1996) 1-9
8. Behr M.A., Wilson M.A., Gill W.P., et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 5419 (1999) 1520-1523
9. Mollenkopf H.J., Kursar M., and Kaufmann S.H. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Mycobacterium bovis bacille Calmette-Guerin induce equal protection. J Infect Dis 190 3 (2004) 588-597
10. Manca C., Tsenova L., Bergtold A., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 98 10 (2001) 5752-5757
11. Morris S.L. The pre-clinical assessment of vaccine-induced protection using different M. tuberculosis challenge strains. Proceedings of the Second International Conference on TB vaccines for the World. Vienna, Austria (2006)
12. Glynn J.R., Whiteley J., Bifani P.J., Kremer K., and van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8 8 (2002) 843-849
13. Bifani P.J., Mathema B., Kurepina N.E., and Kreiswirth B.N. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 10 1 (2002) 45-52
14. Lopez B., Aguilar D., Orozco H., et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133 1 (2003) 30-37
15. Castanon-Arreola M., Lopez-Vidal Y., Espitia-Pinzon C., and Hernandez-Pando R. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Tuberculosis (Edinb) 85 1/2 (2005) 115-126
16. Grode L., Seiler P., Baumann S., et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 115 9 (2005) 2472-2479
17. Tsenova L., Sokol K., Freedman V.H., and Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis 177 6 (1998) 1563-1572
18. Tsenova L., Harbacheuski R., Moreira A.L., et al. Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitis. Infect Immun 74 4 (2006) 2392-2401
19. Tsenova L., Ellison E., Harbacheuski R., et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 192 1 (2005) 98-106
20. Sreevatsan S., Pan X., Stockbauer K.E., et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 94 18 (1997) 9869-9874
21. Manca C., Tsenova L., Barry III C.E., et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 162 11 (1999) 6740-6746
22. Skeiky Y.A., Alderson M.R., Ovendale P.J., et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol 172 12 (2004) 7618-7628
23. Brandt L., Skeiky Y.A., Alderson M.R., et al. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infect Immun 72 11 (2004) 6622-6632
24. Orme I.M., McMurray D.N., and Belisle J.T. Tuberculosis vaccine development: recent progress. Trends Microbiol 9 3 (2001) 115-118
25. Sambandamurthy V.K., Derrick S.C., Hsu T., et al. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24 37-39 (2006) 6309-6320
26. Sampson S.L., Dascher C.C., Sambandamurthy V.K., et al. Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs. Infect Immun 72 5 (2004) 3031-3037
27. Manabe Y.C., Dannenberg Jr. A.M., Tyagi S.K., et al. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect Immun 71 10 (2003) 6004-6011
28. Valway S.E., Sanchez M.P., Shinnick T.F., et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 338 10 (1998) 633-639
29. Bifani P.J., Mathema B., Liu Z., et al. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 282 24 (1999) 2321-2327
30. van Soolingen D., Qian L., de Haas P.E., et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 33 12 (1995) 3234-3238
31. Bifani P.J., Plikaytis B.B., Kapur V., et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275 6 (1996) 452-457
32. Espinal M.A. The global situation of MDR-TB. Tuberculosis (Edinb) 83 1-3 (2003) 44-51
33. Abebe F., and Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link?. Clin Exp Immunol 145 3 (2006) 389-397
34. Pheiffer C., Betts J.C., Flynn H.R., Lukey P.T., and van Helden P. Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv. Microbiology 151 Pt 4 (2005) 1139-1150